Literature DB >> 17186864

Investigation of a novel, heritable bleeding diathesis of Thoroughbred horses and development of a screening assay.

Jeffrey W Norris1, Suzanne M Pratt, Joong-Hyuck Auh, Sandra J Wilson, Dana Clutter, K Gary Magdesian, Gregory L Ferraro, Fern Tablin.   

Abstract

BACKGROUND: Bleeding in racing horses associated with exercise appears to be multifactorial, and clinical investigation into severe cases rarely occurs. Previously, we reported a severe bleeding diathesis in a Thoroughbred mare. Herein, we describe the cellular physiology of this defect, provide a diagnostic tool for identifying it, and demonstrate that the dysfunction is heritable. HYPOTHESIS: The subject has a heritable defect in platelet secretion that reduces thrombin generation in the absence of additional plasma factors and delays the onset of thrombin production even in the presence of these factors. ANIMALS: The study included 3 clinically normal Thoroughbred horses: the subject and her offspring.
METHODS: Washed platelets were examined for their ability to (1) translocate phosphatidylserine to the outer leaflet of the platelet membrane as determined by annexin-V binding, (2) generate thrombin as assessed by the activity of the prothrombinase enzyme complex, and (3) bind fibrinogen and form aggregates as determined by flow cytometry.
RESULTS: Subject and offspring platelets created procoagulant surfaces by translocating phosphatidylserine. The subject's platelets demonstrated reduced prothrombinase activity, resulting in decreased production of thrombin relative to control platelets. Subject and offspring platelets bound less fibrinogen than control platelets when stimulated with thrombin. CONCLUSIONS AND CLINICAL IMPORTANCE: The subject mare has a transmissible defect that involves reduced generation of thrombin by activated platelets, resulting in decreased aggregation and ineffective clotting. A flow cytometric assay of fibrinogen binding to washed platelets discriminates individuals with this platelet dysfunction and may be useful for discerning subclinical congenital or acquired platelet dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186864     DOI: 10.1892/0891-6640(2006)20[1450:ioanhb]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  5 in total

1.  Platelet activation in cats with hypertrophic cardiomyopathy.

Authors:  F Tablin; T Schumacher; M Pombo; C T Marion; K Huang; J W Norris; K E Jandrey; M D Kittleson
Journal:  J Vet Intern Med       Date:  2014-02-24       Impact factor: 3.333

2.  Association of Factor V Secretion with Protein Kinase B Signaling in Platelets from Horses with Atypical Equine Thrombasthenia.

Authors:  J W Norris; M Pombo; E Shirley; G Blevins; F Tablin
Journal:  J Vet Intern Med       Date:  2015-08-19       Impact factor: 3.333

3.  Prevalence of the Mutations Responsible for Glanzmann Thrombasthenia in Horses in Brazil.

Authors:  Raíssa O Leite; Júlia F Ferreira; César E T Araújo; Diego J Z Delfiol; Regina K Takahira; Alexandre S Borges; Jose P Oliveira-Filho
Journal:  Animals (Basel)       Date:  2019-11-13       Impact factor: 2.752

Review 4.  Genetics of equine bleeding disorders.

Authors:  Anna R Dahlgren; Fern Tablin; Carrie J Finno
Journal:  Equine Vet J       Date:  2020-06-23       Impact factor: 2.888

5.  Platelet Activation and Clopidogrel Effects on ADP-Induced Platelet Activation in Cats with or without the A31P Mutation in MYBPC3.

Authors:  R H L Li; J A Stern; V Ho; F Tablin; S P Harris
Journal:  J Vet Intern Med       Date:  2016-09-12       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.